Dec 06, 2022 / 01:00PM GMT
Operator
Welcome to the Achilles Therapeutics ESMO IO Interim Update Conference Call. At this time, all participants are in a listen-only mode. Following management's prepared remarks, we will hold a brief question and answer session.
As a reminder, this call is being recorded today, Tuesday, December 6th, 2022.
I would now turn the call over to Lee Stern, Vice President, Investor Relations at Achilles. Lee, you may begin.
Lee Stern - Achilles Therapeutics - VP, IR and External Communications
Thank you. Hello everyone, and welcome to the Achilles Therapeutics ESMO IO Interim Update Conference Call.
Joining me today on today's call are Dr. Iraj Ali, our Chief Executive Officer; Dr. Karl Peggs, our Chief Medical Officer; and Dr. Sergio Quezada, our Chief Scientific Officer. After our formal remarks, we will conduct a question-and-answer session.
Earlier today, Achilles issued a press release announcing updated income results from the ongoing phase I/IIa CHIRON and THETIS clinical trials that were presented as part of a poster session
Achilles Therapeutics PLC ESMO IO Webcast Call Transcript
Dec 06, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers